I’m excited to share a more detailed look into my professional journey and the work I’ve been fortunate to lead at the intersection of AI, data science, and drug discovery. Over the years, I’ve focused on building data-driven strategies and platforms that help translate complex biological data into meaningful therapeutic impact. I’m grateful for the opportunity to collaborate with incredible teams and contribute to innovation in biotech. Here is my biography.

Bridging the gap between academic research and commercial success requires more than breakthrough science — it demands intentional alignment between discovery and real-world application. Too often, transformative innovations stall not because they lack merit, but because commercial strategy, ecosystem support, and early market validation enter the conversation too late. By fostering earlier collaboration between researchers, investors, and industry leaders — and by building strong network infrastructure that supports translation — institutions can dramatically increase the likelihood that scientific discoveries evolve into scalable, impactful solutions. When commercialization is viewed not as a departure from academia but as an extension of it, research achieves its highest potential: meaningful, measurable impact beyond the lab.

Dr. Lukas J. Farbiak is a biomedical engineering innovator and academic leader whose work in genetic medicine is transforming how diseases are treated at the molecular level. As an Assistant Professor at UT Southwestern and Co-Founder of Signify Bio, Inc., he merges deep scientific expertise with translational impact—developing advanced lipid nanoparticle platforms and signal peptide technologies that enable precise, tissue-specific delivery of therapeutic nucleic acids. With over 15 peer-reviewed publications and 20+ patent filings, Dr. Farbiak stands at the cutting edge of non-viral drug delivery and personalized therapeutics, bringing a rare blend of academic rigor, entrepreneurial vision, and collaborative leadership to every endeavor.

After 25+ years working at the intersection of science and strategy in cell and gene therapy, I’m excited to share a comprehensive look into my professional journey—from hands-on scientific innovation to leadership across CDMOs, biotech, and academic institutions. My passion lies in building high-impact teams, developing therapies that matter, and bridging ideas to execution. Here is my biography.

Klodjan Stafa is a visionary biomedical research leader with a proven track record of advancing innovation at the intersection of dermatology, neuroscience, and molecular biology. With over 15 years of experience spanning academia and industry, he leads high-impact R&D initiatives that drive product development and business growth on a global scale. Known for his ability to cultivate top-performing teams and foster strategic partnerships, Klodjan combines scientific depth with business acumen to deliver breakthrough solutions. His work has contributed to multi-million dollar product launches, influential publications, and patented technologies, positioning him as a trusted voice in translational science and a catalyst for meaningful change in biomedical research.

Deb Kelly is a pioneering leader in biomedical research, known for her expertise in molecular biophysics, computational modeling, and high-resolution imaging to advance translational medicine. As Executive Director of Structural Oncology LLC and a professor at Penn State University, she has led groundbreaking research in cancer and viral health threats, integrating artificial intelligence and bioinformatics to drive drug discovery and clinical decision-making. With over 15 years of experience managing multidisciplinary teams, securing millions in research funding, and mentoring early-career professionals, Kelly’s work has had a lasting impact on biomedical science. Her strategic leadership, innovative research, and commitment to mentorship continue to shape the future of medical advancements and therapeutic development.

I’m excited to share my professional journey as an academician, researcher, and innovator in dental science and biotechnology. From global collaborations to impactful research, my work focuses on advancing education, translational research, and healthcare solutions. Here is my biography.

I’m excited to share a glimpse into my professional journey and achievements. With a Ph.D. in Immunology from the Hebrew University of Jerusalem and extensive experience at the National Institute of Allergy and Infectious Diseases (NIAID), I’ve had the privilege of leading transformative research in cancer immunotherapy and PET imaging of cancer biomarkers. My work has focused on advancing personalized medicine and targeted therapies, and I’m passionate about driving innovation in these fields. I invite you to explore my career highlights and contributions, which reflect my commitment to impactful research and visionary leadership. Thank you for your support and interest!